Sleep Apnea Completed Phase 0 Trials for Remifentanil (DB00899)

Also known as: Sleep apnoeas / Sleep Apnoea / Sleep Apnea Syndrome / Apnea, Sleep / Sleep Apnea Syndromes / Sleep apnoea syndromes / Sleep apnoea syndrome / Apnea syndrome / Apnoea syndrome

IndicationStatusPhase
DBCOND0030087 (Sleep Apnea)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02898792Remifentanil in Adults With OSABasic Science